medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2023,
Номер
unknown
Опубликована: Июль 16, 2023
ABSTRACT
Introduction
While
older
adults
generally
mount
weaker
antibody
responses
to
a
primary
COVID-19
vaccine
series,
T-cell
remain
less
well
characterized
in
this
population.
We
compared
SARS-CoV-2
spike-specific
after
two-
and
three-dose
mRNA
vaccination
subsequent
breakthrough
infection
younger
adults.
Methods
quantified
CD4+
CD8+
T-cells
reactive
overlapping
peptides
spanning
the
ancestral
spike
protein
40
(median
age
79)
50
health
care
workers
39),
all
naive,
using
an
activation
induced
marker
assay.
were
further
assessed
24
participants,
including
8
adults,
who
subsequently
experienced
their
first
infection.
Results
A
third
dose
significantly
boosted
frequencies
above
two-dose
levels
did
not
differ
between
either
dose.
Multivariable
analyses
adjusting
for
sociodemographic,
vaccine-related
variables
confirmed
that
was
associated
with
impaired
cellular
responses.
Instead,
strongest
predictors
of
post-third-dose
corresponding
post-second-dose
frequencies.
Breakthrough
increased
both
T
cell
frequencies,
comparable
Exploratory
revealed
association
HLA-A*02:03
higher
post-vaccination
which
may
be
attributable
numerous
strong-binding
HLA-A*02:03-specific
epitopes
spike.
Conclusion
Older
robust
vaccination,
are
following
Nature,
Год журнала:
2023,
Номер
620(7972), С. 128 - 136
Опубликована: Июль 19, 2023
Abstract
Studies
have
demonstrated
that
at
least
20%
of
individuals
infected
with
SARS-CoV-2
remain
asymptomatic
1–4
.
Although
most
global
efforts
focused
on
severe
illness
in
COVID-19,
examining
infection
provides
a
unique
opportunity
to
consider
early
immunological
features
promote
rapid
viral
clearance.
Here,
postulating
variation
the
human
leukocyte
antigen
(
HLA
)
loci
may
underly
processes
mediating
infection,
we
enrolled
29,947
individuals,
for
whom
high-resolution
genotyping
data
were
available,
smartphone-based
study
designed
track
COVID-19
symptoms
and
outcomes.
Our
discovery
cohort
n
=
1,428)
comprised
unvaccinated
who
reported
positive
test
result
SARS-CoV-2.
We
tested
association
five
disease
course
identified
strong
between
HLA-B*15:01
observed
two
independent
cohorts.
Suggesting
this
genetic
is
due
pre-existing
T
cell
immunity,
show
cells
from
pre-pandemic
samples
carrying
reactive
immunodominant
S-derived
peptide
NQKLIANQF.
The
majority
displayed
memory
phenotype,
highly
polyfunctional
cross-reactive
derived
seasonal
coronaviruses.
crystal
structure
HLA-B*15:01–peptide
complexes
demonstrates
peptides
NQKLIANQF
NQKLIANAF
(from
OC43-CoV
HKU1-CoV)
share
similar
ability
be
stabilized
presented
by
HLA-B*15:01.
Finally,
structural
similarity
underpins
cross-reactivity
high-affinity
public
receptors,
providing
molecular
basis
-mediated
immunity.
Genes and Immunity,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 24, 2025
Genetic
variation
in
the
human
leukocyte
antigen
(HLA)
region
is
thought
to
influence
susceptibility
and
severity
of
a
variety
infectious
diseases.
Several
studies
have
explored
possible
relationship
between
HLA
genetics
SARS-CoV-2
infection,
although
mixed
results,
small
sample
sizes,
difficulty
controlling
for
exposure
risk
made
it
difficult
draw
firm
conclusions.
Here,
dataset
419,234
subjects
with
genotype
data
COVID-19
PCR
test
results
was
studied.
A
baseline
analysis
performed
examine
association
non-HLA
factors
on
positivity.
Then,
multivariate
logistic
regressions,
incorporating
single
paired
alleles,
were
then
corrected
significant
from
analysis.
Proxies
socioeconomic
status
significantly
associated
positivity
across
all
ancestry
groups
Forty-one
alleles
displayed
positivity;
after
risk,
only
eight
associations
remained.
Additionally,
two
allele
pairs
correction.
Of
variables,
showed
greatest
effect
size.
The
this
study
suggest
that
many,
if
not
all,
reported
infection
may
be
spurious,
owing
confounding
factors.
Mobile Information Systems,
Год журнала:
2023,
Номер
2023, С. 1 - 14
Опубликована: Апрель 20, 2023
The
pharmaceutical
company
is
key
to
having
a
strong
healthcare
system,
and
excellent
essential
for
every
society
economy.
However,
there
are
significant
concerns
with
medication
safety
security
as
result
of
fake
inferior
medical
items,
which
constitute
hazard
harm
consumers’
health.
Globally,
drug
counterfeiting
severe
problem
that
endangers
the
public’s
health
well
consumers.
global
business
manufacturing
medications
generates
enormous
annual
revenue.
To
have
quality
industry
great
importance
plays
vital
role
in
medicine
supplies.
With
emerging
computer
technologies
like
blockchain
IoT
cutting
across
several
industries
sectors
revolutionizing
world,
systematic
literature
review
various
articles
chosen
from
different
databases
was
carried
out
this
study
analyze
evaluate
application
areas
technology
existing
frameworks
been
proposed
solve
problems
faced
industry.
outcome
showed
hybrid
framework
can
assist
reducing
counterfeit
provide
solutions
most
This
also
addressed
drawbacks
Extreme
polymorphism
of
HLA
and
killer‐cell
immunoglobulin‐like
receptors
(KIR)
differentiates
immune
responses
across
individuals.
Additional
to
T
cell
receptor
interactions,
subsets
class
I
act
as
ligands
for
inhibitory
activating
KIR,
allowing
natural
killer
(NK)
cells
detect
kill
infected
cells.
We
investigated
the
impact
KIR
on
severity
COVID‐19.
High
resolution
II
genotypes
were
determined
from
403
non‐hospitalized
1575
hospitalized
SARS‐CoV‐2
patients
Italy
collected
in
2020.
observed
that
possession
KIR2DS4*001
allotype
is
associated
with
severe
disease,
requiring
hospitalization
(OR
=
1.48,
95%
CI
1.20–1.85,
p
c
0.017),
this
effect
greater
individuals
homozygous
3.74,
1.75–9.29,
0.003).
also
allotype,
HLA‐DPB1*13:01
protects
disease
0.49,
0.33–0.74,
0.019).
These
association
analyses
replicated
using
logistic
regression
sex
age
covariates.
Autoantibodies
against
IFN‐α
COVID‐19
detected
26%
156
tested.
HLA‐C*08:02
was
more
frequent
autoantibodies
than
those
without,
KIR3DL1*01502
only
present
lacking
antibodies.
findings
suggest
integral
determining
clinical
outcome
following
infection,
by
influencing
course
both
innate
adaptive
immunity.
Infectious Disease Reports,
Год журнала:
2024,
Номер
16(2), С. 380 - 406
Опубликована: Апрель 18, 2024
The
coronavirus
disease
2019
(COVID-19)
has
left
a
devasting
effect
on
various
regions
globally.
Africa
exceptionally
high
rates
of
other
infectious
diseases,
such
as
tuberculosis
(TB),
human
immunodeficiency
virus
(HIV),
and
malaria,
was
not
impacted
by
COVID-19
to
the
extent
continents
Globally,
caused
approximately
7
million
deaths
700
infections
thus
far.
severity
susceptibility
vary
among
individuals
populations,
which
could
be
attributed
factors,
including
viral
strain,
host
genetics,
environment,
lifespan,
co-existing
conditions.
Host
genetics
play
substantial
part
in
individuals.
Human
leukocyte
antigen
(HLA)
previously
been
shown
very
important
across
immune
responses
against
viruses.
HLA
widely
studied
gene
region
for
associations
that
have
identified.
proteins
present
peptides
cytotoxic
lymphocytes,
causes
an
response
kill
infected
cells.
molecule
serves
central
association;
therefore,
we
expect
association
with
COVID-19.
Therefore,
this
narrative
review,
look
at
region,
particularly,
class
I,
understand
its
role
disease.
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Фев. 16, 2024
This
study
aimed
to
delineate
longitudinal
antibody
responses
the
Pfizer-BioNTech
BNT162b2
COVID-19
vaccine
within
Ugandan
subset
of
Sub-Saharan
African
(SSA)
demographic,
filling
a
significant
gap
in
global
datasets.
We
enrolled
48
participants
and
collected
320
specimens
over
12
months
after
primary
vaccination
dose.
A
validated
enzyme-linked
immunosorbent
assay
(ELISA)
was
used
quantify
SARS-CoV-2-specific
IgG,
IgM,
IgA
concentrations
(ng/ml)
optical
densities
(ODs).
Statistical
analyses
included
box
plots,
diverging
bar
graphs,
Wilcoxon
test
with
Bonferroni
correction.
noted
robust
S-IgG
response
14
days
dose,
which
consistent
data.
There
no
surge
levels
booster
contrasting
trends
other
populations.
The
S-IgM
transient
predominantly
below
established
thresholds
for
this
population,
reflects
its
typical
early
emergence
rapid
decline.
S-IgA
rose
initial
dose
then
decreased
six
months,
aligning
temporal
patterns
mucosal
immunity.
Eleven
breakthrough
infections
were
noted,
all
asymptomatic,
regardless
participants'
serostatus,
suggests
protective
effect
from
vaccination.
elicited
strong
SSA
demographic.
dynamics
distinctly
differed
data
highlighting
significance
region-specific
research
necessity
customised
strategies.
Pathogens and Immunity,
Год журнала:
2023,
Номер
8(1), С. 117 - 135
Опубликована: Ноя. 17, 2023
Introduction:
While
older
adults
generally
mount
weaker
antibody
responses
to
a
primary
COVID-19
vaccine
series,
T-cell
remain
less
well
characterized
in
this
population.
We
compared
SARS-CoV-2
spike-specific
after
2-
and
3-dose
mRNA
vaccination
subsequent
breakthrough
infection
younger
adults.
Methods:
quantified
CD4+
CD8+
T-cells
reactive
overlapping
peptides
spanning
the
ancestral
spike
protein
40
(median
age
79)
50
health
care
workers
39),
all
naive,
using
an
activation-induced
marker
assay.
were
further
assessed
24
participants,
including
8
adults,
who
subsequently
experienced
their
first
infection.
Results:
A
third
dose
significantly
boosted
frequencies
above
2-dose
levels
did
not
differ
between
either
dose.
Multivariable
analyses
adjusting
for
sociodemographic,
health,
vaccine-related
variables
confirmed
that
was
associated
with
impaired
cellular
responses.
Instead,
strongest
predictors
of
post-third-dose
corresponding
post-second-dose
frequencies.
Breakthrough
increased
both
frequencies,
comparable
Exploratory
revealed
association
HLA-A*02:03
higher
post-vaccination
which
may
be
attributable
numerous
strong-binding
HLA-A*02:03-specific
epitopes
protein.
Conclusion:
Older
robust
vaccination,
are
following
Few
data
exist
on
the
role
of
genetic
factors
involving
HLA
system
response
to
Covid‐19
vaccines.
Moving
from
suggestions
a
previous
study
investigating
association
some
alleles
with
humoral
BNT162b2,
we
here
compared
allele
frequencies
among
weak
(
n
=
111)
and
strong
123)
responders,
defined
as
those
healthcare
workers
lowest
highest
anti‐Spike
antibody
levels
after
vaccination.
Individuals
clinical
history
or
positive
anti‐nucleocapside
antibodies
were
excluded.
We
found
common
HLA‐A*03:01
an
independent
predictor
(OR
12.46,
95%
CI:
4.41–35.21,
p
<
0.0001),
together
younger
age
vaccines
0.004).
Correlation
between
protection
breakthrough
infection
has
been
observed,
2‐year
cumulative
incidence
42%
63%
respectively
0.03).
Due
high
frequency
need
for
seasonal
vaccinations
against
SARS‐CoV‐2
mutants,
our
findings
provide
useful
information
about
inter‐individual
differences
observed
in
vaccine
might
support
further
studies
next
The
SARS-CoV-2
pandemic
continues
to
pose
a
global
threat.
While
its
virulence
has
subsided,
it
persisted
due
the
continual
emergence
of
new
mutations.
Although
many
high-risk
conditions
related
COVID-19
have
been
identified,
understanding
protective
factors
remains
limited.
Intriguingly,
epidemiological
evidence
suggests
low
incidence
COVID-19-infected
CD
patients.
present
study
explores
whether
their
genetic
background,
namely
associated
HLA-DQs,
offers
protection
against
severe
outcomes.
We
hypothesize
that
HLA-DQ
2/8
alleles
may
shield
patients
from
and
subsequent
effects,
possibly
memory
CD4
T
cells
primed
by
previous
exposure
human-associated
common
cold
coronaviruses
(CCC)
higher
affinity
those
allele's
groove.
In
this
context,
we
examined
potential
cross-reactivity
between
epitopes
CCC
assessed
binding
(BA)
these
2/8.
Using
computational
methods,
analyzed
sequence
similarity
four
distinct
CCC.
Of
924
unique
immunodominant
15-mer
with
at
least
67%
identity,
37
exhibited
significant
BA
2/8,
suggesting
effect.
various
mechanisms
might
explain
role
HLA-DQ2/8
in
COVID-19-afflicted
If
substantiated,
insights
could
enhance
our
gene-environment
enigma
viral-host
relationship,
guiding
therapeutic
innovations
ongoing
pandemic.